Home > Balance Sheet > NATCO PHARMA

NATCO PHARMA
Sundry Debtors

    Back to Balance Sheet
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Sundry Debtors History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Sundry Debtors ₹1,247 Cr₹1,189 Cr₹856 Cr₹621 Cr₹413 Cr

What is the latest Sundry Debtors ratio of NATCO PHARMA ?

The latest Sundry Debtors ratio of NATCO PHARMA is ₹1,247 Cr based on Mar2025 Consolidated results.
Year Sundry Debtors
Mar2025₹1,247 Cr
Mar2024₹1,189 Cr
Mar2023₹856 Cr
Mar2022₹621 Cr
Mar2021₹413 Cr

How is Sundry Debtors of NATCO PHARMA Trending?

Years Sundry Debtors % Change
Mar2025 ₹1,247 Cr
4.85
Mar2024 ₹1,189 Cr
38.87
Mar2023 ₹856 Cr
37.95
Mar2022 ₹621 Cr
50.30
Mar2021 ₹413 Cr -

Compare Sundry Debtors of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹18,210.0 Cr -13.1% -7.1% 33.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹432,096.0 Cr -2.4% 3% 9.6% Stock Analytics
DIVIS LABORATORIES ₹176,807.0 Cr -3.3% 3.5% 4.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹148,718.0 Cr -2% 5% 43.1% Stock Analytics
CIPLA ₹112,971.0 Cr -0% 6.9% -4.5% Stock Analytics
DR REDDYS LABORATORIES ₹108,752.0 Cr -0.3% -3.8% 7.3% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-13.1%

-7.1%

33.6%

SENSEX

-0.5%

-3.3%

-7.6%


You may also like the below Video Courses